ES2171697T3 - Antagonistas del receptor de endotelina. - Google Patents

Antagonistas del receptor de endotelina.

Info

Publication number
ES2171697T3
ES2171697T3 ES96926243T ES96926243T ES2171697T3 ES 2171697 T3 ES2171697 T3 ES 2171697T3 ES 96926243 T ES96926243 T ES 96926243T ES 96926243 T ES96926243 T ES 96926243T ES 2171697 T3 ES2171697 T3 ES 2171697T3
Authority
ES
Spain
Prior art keywords
endotheline
receiver
receiver antagonists
antagonists
anothonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96926243T
Other languages
English (en)
Inventor
Juan Ignacio Luengo
John Duncan Elliott
Jia-Ning Xiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2171697T3 publication Critical patent/ES2171697T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBEN UNOS NUEVOS PIRROLES, PIRAZOLES Y TRIAZOLES, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS Y SU USO COMO ANTAGONISTAS DEL RECEPTOR ENDOTELINA.
ES96926243T 1995-08-02 1996-08-02 Antagonistas del receptor de endotelina. Expired - Lifetime ES2171697T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1098296P 1996-02-01 1996-02-01

Publications (1)

Publication Number Publication Date
ES2171697T3 true ES2171697T3 (es) 2002-09-16

Family

ID=26669471

Family Applications (2)

Application Number Title Priority Date Filing Date
ES96926243T Expired - Lifetime ES2171697T3 (es) 1995-08-02 1996-08-02 Antagonistas del receptor de endotelina.
ES96928036T Expired - Lifetime ES2273350T3 (es) 1995-08-02 1996-08-02 Antagonistas de los receptores de endotelina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES96928036T Expired - Lifetime ES2273350T3 (es) 1995-08-02 1996-08-02 Antagonistas de los receptores de endotelina.

Country Status (25)

Country Link
US (5) US5969151A (es)
EP (2) EP0841925B1 (es)
JP (2) JP2001517195A (es)
KR (1) KR19990036032A (es)
CN (1) CN1196680A (es)
AP (1) AP9801182A0 (es)
AT (1) ATE341324T1 (es)
AU (2) AU717172B2 (es)
BG (1) BG102229A (es)
BR (1) BR9609914A (es)
CA (2) CA2228293A1 (es)
CZ (1) CZ30498A3 (es)
DE (2) DE69636597T2 (es)
EA (1) EA000952B1 (es)
ES (2) ES2171697T3 (es)
HU (1) HU220776B1 (es)
MX (1) MX9800975A (es)
NO (1) NO980422L (es)
NZ (1) NZ315846A (es)
OA (1) OA10755A (es)
PL (1) PL184272B1 (es)
RO (1) RO115802B1 (es)
SK (1) SK282584B6 (es)
TR (1) TR199800152T1 (es)
WO (2) WO1997004773A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017426A1 (es) * 1997-12-08 2001-09-05 Smithkline Beecham Corp Sal de monoargininilo del acido (e)-3-[1-n-butil-5-[2-(2-carboxifenil)metoxi-4-clorofenil]-1h-pirazol-4-il]-2-[(5-metoxi-2,3-dihidrobenzofuran-6-il)metil]-prop-2-enoico, composicion farmaceutica que la contiene, su uso para la manufactura de un medicamento y procedimiento para su preparacion
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
US10626096B2 (en) 2015-11-24 2020-04-21 Sanford Burnham Prebys Medical Discovery Institute Azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
DK0714897T3 (da) * 1993-08-18 2001-03-19 Banyu Pharma Co Ltd Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
DE69526738T2 (de) * 1994-09-02 2003-02-06 Smithkline Beecham Corp., Philadelphia Endothelin-rezeptor-antagonisten

Also Published As

Publication number Publication date
EP0843551B1 (en) 2002-02-06
OA10755A (en) 2002-12-13
MX9800975A (es) 1998-04-30
CZ30498A3 (cs) 1998-07-15
EA000952B1 (ru) 2000-08-28
US5958968A (en) 1999-09-28
EA199800185A1 (ru) 1998-10-29
AU6764596A (en) 1997-02-26
US5969151A (en) 1999-10-19
EP0841925A1 (en) 1998-05-20
EP0841925A4 (en) 2001-10-17
PL184272B1 (pl) 2002-09-30
JPH11511133A (ja) 1999-09-28
CA2228296A1 (en) 1997-02-13
DE69636597D1 (de) 2006-11-16
JP2001517195A (ja) 2001-10-02
WO1997004773A1 (en) 1997-02-13
DE69636597T2 (de) 2007-08-16
EP0843551A4 (en) 1998-08-12
AU6646396A (en) 1997-02-26
HU220776B1 (hu) 2002-05-28
AU717172B2 (en) 2000-03-16
NO980422D0 (no) 1998-01-30
RO115802B1 (ro) 2000-06-30
CN1196680A (zh) 1998-10-21
BG102229A (en) 1998-09-30
KR19990036032A (ko) 1999-05-25
SK11398A3 (en) 1998-07-08
BR9609914A (pt) 1999-07-06
HUP9902817A2 (hu) 1999-12-28
CA2228293A1 (en) 1997-02-13
PL324745A1 (en) 1998-06-08
AP9801182A0 (en) 1998-01-31
WO1997004772A1 (en) 1997-02-13
EP0843551A1 (en) 1998-05-27
US6353116B1 (en) 2002-03-05
TR199800152T1 (xx) 1998-05-21
SK282584B6 (sk) 2002-10-08
HUP9902817A3 (en) 2001-03-28
NO980422L (no) 1998-03-24
EP0841925B1 (en) 2006-10-04
US6096897A (en) 2000-08-01
ES2273350T3 (es) 2007-05-01
DE69619116T2 (de) 2002-09-19
US6482956B2 (en) 2002-11-19
ATE341324T1 (de) 2006-10-15
NZ315846A (en) 1999-01-28
US20020072614A1 (en) 2002-06-13
DE69619116D1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
CR6478A (es) Moduladores del receptor glucocorticoide
CL2004001128A1 (es) Compuestos derivados de halogenopirimidinas aril eter; composicion pesticida; procedimiento de preparacion; compuestos intermediarios; y uso del compuesto como agente pesticida.
UY24553A1 (es) Compuestos insecticidas de tipo 5- amino -4-etilsulfinil-pirazol
TR200002896T2 (tr) Kalsilitik Bileşimler
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
BR0113980A (pt) Compostos de succinimida heterocìclicos fundidos e seus análogos, moduladores de função de receptor de hormÈnio nuclear
PA8435001A1 (es) Derivados 6,6-heterobiciclicos sustituidos.
CL2004001102A1 (es) Compuestos derivados de 2-amino-4-bicicloamino-1,3,5-triazinas; composicion herbicida que los contiene; procedimiento de preparacion; uso de dichos compuestos; y compuestos intermediarios.
ES2153907T3 (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y su uso como antagonistas del receptor 5ht1d.
BG103548A (en) Vitronectine receptor antagonists
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
GT199700009A (es) Terapia combinada para la osteoporosis.
AR002268A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
ES2190487T3 (es) Nuevos agonistas y antagonistas del receptor de adenosina a1.
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
SV2002000005A (es) Heterociclos 2-arilimino substituidos y composiciones que los contienen para usar como agentes que ligan el receptor de la progesterona ref. 5048p1-sv
ES2166462T3 (es) Antagonistas del receptor de la endotelina.
ES2195002T3 (es) Antagonistas de los receptores de la endotelina.
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
ATE217619T1 (de) Endothelin-rezeptor-antagonisten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 843551

Country of ref document: ES